✨
AI Summary
- The Yescarta CAR-T therapy launch faced both successes and challenges.
- Consultant Harris Kaplan shares insights from physician and administrator interviews.
- The discussion examines commercial strategy for Kite Pharma's therapy.
Guests on This Episode
HK
Harris Kaplan
1 podcast appearance